Taysha Gene Therapies, Inc. TSHA Issuance of warrants
Issuance of warrants at other companies
Other financials
Where this comes from
Reported directly by Taysha Gene Therapies, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued.
The official record: Taysha Gene Therapies, Inc.’s 10-K, filed March 19, 2026, on SEC EDGAR. View the filing →
Ask your AI about Taysha Gene Therapies, Inc.'s issuance of warrants.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Taysha Gene Therapies, Inc.'s issuance of warrants?
- Taysha Gene Therapies, Inc. (TSHA) reported issuance of warrants of $409.25K in Q4 2025.
- What does issuance of warrants mean?
- Represents the accounting adjustments made to equity accounts resulting from the issuance of warrants. This metric reflects the dilution impact and the non-cash financing component associated with equity-linked instruments. It is a key indicator of how the company manages its capital structure and potential future share dilution.